These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17452686)

  • 21. ECG diagnosis: flecainide toxicity.
    Levis JT
    Perm J; 2012; 16(4):53. PubMed ID: 23251119
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypokalaemia in hypertensive patients treated with diuretics: no increase in cardiac arrhythmias.
    Haalboom JR; Bouter H; Kuyer PP; Struyvenberg A
    Neth J Med; 1989 Feb; 34(1-2):81-7. PubMed ID: 2915738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diuretic-induced hypokalaemia: an updated review.
    Lin Z; Wong LYF; Cheung BMY
    Postgrad Med J; 2022 Jun; 98(1160):477-482. PubMed ID: 33688065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum electrolytes and drug therapy of patients admitted to a geriatric department].
    Sørensen IJ; Matzen LE
    Ugeskr Laeger; 1993 Nov; 155(48):3921-4. PubMed ID: 8273199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide-induced myoclonus.
    Velasco SL; Sierra-Hidalgo F; Rodríguez RM; Guerreo AJ; Morales JR
    Clin Neuropharmacol; 2014; 37(2):65-6. PubMed ID: 24614665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyponatraemia and hypokalaemia due to indapamide.
    Chapman MD; Hanrahan R; McEwen J; Marley JE
    Med J Aust; 2002 Mar; 176(5):219-21. PubMed ID: 11999238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of oral flecainide treatment of refractory tachyarrhythmias].
    Sakurada H; Hiyoshi Y; Tejima T; Yanase O; Tokuyasu Y; Watanabe K; Motomiya T; Sugiura M; Hiraoka M
    Kokyu To Junkan; 1990 May; 38(5):471-6. PubMed ID: 2115193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrolyte disorders caused by drugs].
    Radó J
    Orv Hetil; 1988 Jan; 129(1):25-31. PubMed ID: 3281087
    [No Abstract]   [Full Text] [Related]  

  • 32. [Short- and medium-term treatment of ventricular hyperkinetic arrhythmia with flecainide].
    Gallicchio F; Aragona PL; Chiatto M; Pugliese F; Donnangelo L
    Clin Ter; 1989 May; 129(3):173-84. PubMed ID: 2527112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of antihypertensive monotherapy with serum sodium and potassium levels in Chinese patients.
    Jiang JY; Wong MC; Ali MK; Griffiths SM; Mercer SW
    Am J Hypertens; 2009 Mar; 22(3):243-9. PubMed ID: 19131933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypokalemia and arrhythmia during acute myocardial infarct in patients on long-term diuretic treatment].
    Nesje OA
    Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1257-9. PubMed ID: 968854
    [No Abstract]   [Full Text] [Related]  

  • 35. [QT prolongation and induction of torsades de pointe by flecainide. Apropos of a case].
    Wickers F; Haissaguere M; Palussiere J
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1283-5. PubMed ID: 3146965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P; Brembilla-Perrot B; Fauchier JP; Babuty D; Garnier LF; Rouesnel P; Breuillac JC; Funck F; Scheck F; Peraudeau P; Medvedowsky JL
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease.
    Hill NS
    Arch Intern Med; 1986 Jan; 146(1):129-33. PubMed ID: 2867747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes.
    Papadopoulos DP; Papademetriou V
    Clin Exp Hypertens; 2007 Nov; 29(8):503-16. PubMed ID: 18058476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia.
    Struthers AD; Whitesmith R; Reid JL
    Lancet; 1983 Jun; 1(8338):1358-61. PubMed ID: 6134137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.